SCHEMBL6944196

SCHEMBL6944196

CCC[C@](C(=O)NN)(c1ccc(C)cc1[C@H](CNS(=O)(=O)c1cccs1)C(=O)NO)S(C)(=O)=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.35
TSHR P16473 3/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
ATM Q13315 1/20 0.35
CYP3A4 P08684 2/20 0.34
CYP2C9 P11712 2/20 0.34
CYP2C19 P33261 2/20 0.34
KMT2A Q03164 4/20 0.34
MEN1 O00255 3/20 0.34
HTT P42858 2/20 0.34
HPGD P15428 2/20 0.34
LMNA P02545 2/20 0.34
MAPT P10636 2/20 0.33
CYP1A2 P05177 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TP53 P04637 1/20 0.33
POLB P06746 1/20 0.33
KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6942895 0.88 TSHR (0.36) ALDH1A1TSHRNPC1RAB9AATM
SCHEMBL6940036 0.86 TSHR (0.38) ALDH1A1TSHRNPC1RAB9AKMT2A
SCHEMBL6940042 0.85 SMN1; SMN2 (0.33) ALDH1A1TSHRNPC1RAB9AATM
SCHEMBL6941761 0.82 TAS1R3 (0.33)
SCHEMBL6940210 0.80 ALDH1A1 (0.34) ALDH1A1ATMKMT2AMEN1LMNA
SCHEMBL6947687 0.80 HSPA9 (0.31)
SCHEMBL6939946 0.79 NPC1 (0.36) ALDH1A1NPC1RAB9ACYP2C9CYP2C19
SCHEMBL6945854 0.79 ADAM17 (0.37)
SCHEMBL7076167 0.77 ADAM17 (0.39) TSHRLMNA
SCHEMBL6940940 0.77 ADAM17 (0.35) KMT2AMEN1HTTLMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0993442-B1 HYDRAZINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2003-04-23 EP disclosed
US-6235787-B1 ANTIINFLAMMATORY AGENTS; RHEUMATIC DISEASES; BONE DISORDERS; SKIN DISORDERS; MULTIPLE SCLEROSIS HOFFMANN-LA ROCHE INC. 2001-05-22 US disclosed
EP-0993442-A1 HYDRAZINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2000-04-19 EP disclosed
WO-1999001428-A1 HYDRAZINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1999-01-14 WO disclosed